These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10735779)

  • 1. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery?
    Knutson JE; Deering JA; Hall FW; Nuttall GA; Schroeder DR; White RD; Mullany CJ
    Anesth Analg; 2000 Apr; 90(4):801-7. PubMed ID: 10735779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations.
    Cope JT; Banks D; Mauney MC; Lucktong T; Shockey KS; Kron IL; Tribble CG
    Ann Thorac Surg; 1997 Jan; 63(1):78-82; discussion 82-3. PubMed ID: 8993245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
    Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intraoperative hetastarch priming during coronary bypass.
    Canver CC; Nichols RD
    Chest; 2000 Dec; 118(6):1616-20. PubMed ID: 11115448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hetastarch and bleeding complications after coronary artery surgery.
    Avorn J; Patel M; Levin R; Winkelmayer WC
    Chest; 2003 Oct; 124(4):1437-42. PubMed ID: 14555577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass.
    Brutocao D; Bratton SL; Thomas JR; Schrader PF; Coles PG; Lynn AM
    J Cardiothorac Vasc Anesth; 1996 Apr; 10(3):348-51. PubMed ID: 8725415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials.
    Navickis RJ; Haynes GR; Wilkes MM
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):223-30. PubMed ID: 22578894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
    Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
    Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
    London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative blood loss and transfusion associated with use of Hextend in cardiac surgery patients at a blood conservation center.
    Moskowitz DM; Shander A; Javidroozi M; Klein JJ; Perelman SI; Nemeth J; Ergin MA
    Transfusion; 2008 Apr; 48(4):768-75. PubMed ID: 18248568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery.
    Hicks GL; Jensen LA; Norsen LH; Quinn JR; Stewart SS; DeWeese JA
    Ann Thorac Surg; 1985 May; 39(5):422-5. PubMed ID: 2581521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
    Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
    Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of hetastarch and albumin in postoperative cardiac patients.
    Diehl JT; Lester JL; Cosgrove DM
    Ann Thorac Surg; 1982 Dec; 34(6):674-9. PubMed ID: 6184023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why the Food and Drug Administration changed the warning label for hetastarch.
    Haynes GR; Havidich JE; Payne KJ
    Anesthesiology; 2004 Aug; 101(2):560-1. PubMed ID: 15277957
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Perioperative Fluid Replacement Therapy in Lung Transplant Patients.
    Björkbom E; Hämmäinen P; Schramko A
    Exp Clin Transplant; 2017 Feb; 15(1):78-81. PubMed ID: 27855591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming and replenishment in cardiopulmonary bypass with hydroxyethyl starch 130/0.4 decreases fluid overbalance without renal dysfunction or bleeding in adult valve surgery.
    Isoda S; Izubuchi R; Yamazaki I; Nakayama Y; Yano Y; Masuda M
    Gen Thorac Cardiovasc Surg; 2019 Apr; 67(4):374-376. PubMed ID: 30805825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.